Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Zebrafish, a model to develop nanotherapeutics that control neutrophils response during inflammation.

García-López JP, Vilos C, Feijóo CG.

J Control Release. 2019 Nov 10;313:14-23. doi: 10.1016/j.jconrel.2019.10.005. Epub 2019 Oct 14.

PMID:
31622693
2.

N-Acetyl Cysteine attenuates the sarcopenia and muscle apoptosis induced by chronic liver disease.

Abrigo J, Marín T, Aguirre F, Tacchi F, Vilos C, Simon F, Arrese M, Cabrera D, Cabello-Verrugio C.

Curr Mol Med. 2019 Sep 17. doi: 10.2174/1566524019666190917124636. [Epub ahead of print]

PMID:
31530262
3.

Mitochondrial Dysfunction in Skeletal Muscle Pathologies.

Abrigo J, Simon F, Cabrera D, Vilos C, Cabello-Verrugio C.

Curr Protein Pept Sci. 2019;20(6):536-546. doi: 10.2174/1389203720666190402100902. Review.

PMID:
30947668
4.

Oxidative Stress in Disease and Aging: Mechanisms and Therapies 2018.

Cabello-Verrugio C, Vilos C, Rodrigues-Diez R, Estrada L.

Oxid Med Cell Longev. 2018 Sep 23;2018:2835189. doi: 10.1155/2018/2835189. eCollection 2018. No abstract available.

5.

Atomic-level characterization and cilostazol affinity of poly(lactic acid) nanoparticles conjugated with differentially charged hydrophilic molecules.

Matus MF, Ludueña M, Vilos C, Palomo I, Mariscal MM.

Beilstein J Nanotechnol. 2018 May 2;9:1328-1338. doi: 10.3762/bjnano.9.126. eCollection 2018.

6.

A novel alendronate functionalized nanoprobe for simple colorimetric detection of cancer-associated hypercalcemia.

Sahu A, Hwang Y, Vilos C, Lim JM, Kim S, Choi WI, Tae G.

Nanoscale. 2018 Jul 19;10(28):13375-13383. doi: 10.1039/c8nr02570c.

PMID:
29786742
7.

Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia.

Ábrigo J, Elorza AA, Riedel CA, Vilos C, Simon F, Cabrera D, Estrada L, Cabello-Verrugio C.

Oxid Med Cell Longev. 2018 Mar 28;2018:2063179. doi: 10.1155/2018/2063179. eCollection 2018. Review.

8.

Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses.

Matus MF, Vilos C, Cisterna BA, Fuentes E, Palomo I.

Vascul Pharmacol. 2018 Feb;101:1-8. doi: 10.1016/j.vph.2017.11.004. Epub 2017 Nov 22. Review.

PMID:
29174014
9.

TGF-β requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy.

Ábrigo J, Campos F, Simon F, Riedel C, Cabrera D, Vilos C, Cabello-Verrugio C.

Biol Chem. 2018 Feb 23;399(3):253-264. doi: 10.1515/hsz-2017-0217.

PMID:
29140787
10.

Bioinspired Heparin Nanosponge Prepared by Photo-crosslinking for Controlled Release of Growth Factors.

Choi WI, Sahu A, Vilos C, Kamaly N, Jo SM, Lee JH, Tae G.

Sci Rep. 2017 Oct 30;7(1):14351. doi: 10.1038/s41598-017-14040-5.

11.

Intracellular trafficking and cellular uptake mechanism of PHBV nanoparticles for targeted delivery in epithelial cell lines.

Peñaloza JP, Márquez-Miranda V, Cabaña-Brunod M, Reyes-Ramírez R, Llancalahuen FM, Vilos C, Maldonado-Biermann F, Velásquez LA, Fuentes JA, González-Nilo FD, Rodríguez-Díaz M, Otero C.

J Nanobiotechnology. 2017 Jan 3;15(1):1. doi: 10.1186/s12951-016-0241-6.

12.

Targeted brain delivery nanoparticles for malignant gliomas.

Pinto MP, Arce M, Yameen B, Vilos C.

Nanomedicine (Lond). 2017 Jan;12(1):59-72. Epub 2016 Nov 23. Review.

PMID:
27876436
13.

Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles.

Fuentes E, Yameen B, Bong SJ, Salvador-Morales C, Palomo I, Vilos C.

Nanomedicine. 2017 Apr;13(3):1089-1094. doi: 10.1016/j.nano.2016.10.010. Epub 2016 Oct 25.

PMID:
27789259
14.

Targeted nanoparticles for colorectal cancer.

Cisterna BA, Kamaly N, Choi WI, Tavakkoli A, Farokhzad OC, Vilos C.

Nanomedicine (Lond). 2016 Sep;11(18):2443-56. doi: 10.2217/nnm-2016-0194. Epub 2016 Aug 16. Review.

15.

Mechanistic Studies on the Self-Assembly of PLGA Patchy Particles and Their Potential Applications in Biomedical Imaging.

Salvador-Morales C, Brahmbhatt B, Márquez-Miranda V, Araya-Duran I, Canan J, Gonzalez-Nilo F, Vilos C, Cebral J, Mut F, Lohner R, Leong B, Sundaresan G, Zweit J.

Langmuir. 2016 Aug 9;32(31):7929-42. doi: 10.1021/acs.langmuir.6b02177. Epub 2016 Jul 29.

PMID:
27468612
16.

Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis.

Kamaly N, Fredman G, Fojas JJ, Subramanian M, Choi WI, Zepeda K, Vilos C, Yu M, Gadde S, Wu J, Milton J, Carvalho Leitao R, Rosa Fernandes L, Hasan M, Gao H, Nguyen V, Harris J, Tabas I, Farokhzad OC.

ACS Nano. 2016 May 24;10(5):5280-92. doi: 10.1021/acsnano.6b01114. Epub 2016 Apr 28.

17.

Prothrombin C20209T mutation in deep vein thrombosis: a case report.

Muñoz M, Vilos C, Cantín M.

Int J Clin Exp Med. 2015 Jul 15;8(7):11225-9. eCollection 2015.

18.

Drug Delivery Nanocarriers from a Fully Degradable PEG-Conjugated Polyester with a Reduction-Responsive Backbone.

Yameen B, Vilos C, Choi WI, Whyte A, Huang J, Pollit L, Farokhzad OC.

Chemistry. 2015 Aug 3;21(32):11325-9. doi: 10.1002/chem.201502233. Epub 2015 Jul 14.

PMID:
26177931
19.

Preclinical Development and In Vivo Efficacy of Ceftiofur-PLGA Microparticles.

Vilos C, Velasquez LA, Rodas PI, Zepeda K, Bong SJ, Herrera N, Cantin M, Simon F, Constandil L.

PLoS One. 2015 Apr 27;10(4):e0123335. doi: 10.1371/journal.pone.0123335. eCollection 2015.

20.

Multifunctional polymeric nanoparticles doubly loaded with SPION and ceftiofur retain their physical and biological properties.

Solar P, González G, Vilos C, Herrera N, Juica N, Moreno M, Simon F, Velásquez L.

J Nanobiotechnology. 2015 Feb 13;13:14. doi: 10.1186/s12951-015-0077-5.

Supplemental Content

Support Center